Related Experiment Video
Updated: May 11, 2026

07:40
Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders
Published on: April 14, 2017
20.6K
Generating Neuroimmune Assembloids Using Human Induced Pluripotent Stem Cell (iPSC)-Derived Cortical Organoids and
Kriti Kalpana1, Chandrika Rao1, Stefan Semrau1
1The New York Stem Cell Foundation Research Institute, New York, NY, USA.
Methods in Molecular Biology (Clifton, N.J.)
|July 8, 2024
Summary
Researchers developed a new method to create brain organoids with microglia, the brain's immune cells. This neuroimmune assembloid model aids in studying neurological diseases and cell interactions.
Area of Science:
- Neuroscience
- Immunology
- Stem Cell Biology
Background:
- Brain organoids model human neurodevelopment and disease.
- Microglia, the CNS immune cells, are crucial in neurological disorders but often excluded from organoid models.
Purpose of the Study:
- To develop a method for generating neuroimmune assembloids integrating human induced pluripotent stem cell (iPSC)-derived cortical organoids and microglia.
- To provide a comprehensive protocol for studying neuro-immune interactions in vitro.
Main Methods:
- Generation of iPSC-derived cortical organoids.
- Two methods for microglia integration: direct addition or co-aggregation with neuronal progenitors.
- Protocols for single-cell RNA sequencing, fixation, cryosectioning, and immunostaining.
Main Results:
- Successful long-term survival and maturation of microglia within organoids.
- Demonstration of two viable methods for creating neuroimmune assembloids.
- Establishment of protocols for comprehensive downstream analysis.
Conclusions:
- The developed protocol enables the creation of advanced neuroimmune assembloids.
- This model system is valuable for investigating microglia roles in neurological diseases.
- Facilitates research on neuro-immune cell interactions in vitro.
Related Concept Videos
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Source And Potency Of Stem Cells
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

